MCM
ACAD icon

Moore Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Moore Capital Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-200,000
Closed -$8.56M – 158
2019
Q4 		$8.56M Sell
200,000
-41,653
-17% -$1.81M 0.31% 96
2019
Q3 		$8.7M Sell
241,653
-21,673
-8% -$657K 0.41% 89
2019
Q2 		$7.04M Sell
263,326
-44,124
-14% -$1.13M 0.25% 125
2019
Q1 		$8.26M Buy
+307,450
New +$7.18M 0.29% 107
2016
Q1 		– Sell
-100,000
Closed -$3.56M – 234
2015
Q4 		$3.56M Buy
+100,000
New +$3.52M 0.12% 159
2015
Q2 		– Sell
-80,000
Closed -$2.61M – 408
2015
Q1 		$2.61M Buy
+80,000
New +$2.75M 0.09% 242

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return